Ingevity Valuation
Is NGVT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NGVT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NGVT * (MX$1430) is trading below our estimate of fair value (MX$3391.08)
Significantly Below Fair Value: NGVT * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NGVT *?
Key metric: As NGVT * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is NGVT *'s PE Ratio? | |
---|---|
PE Ratio | 9.7x |
Earnings | US$201.50m |
Market Cap | US$1.96b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 7.9x |
PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does NGVT *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.5x | ||
ORBIA * Orbia Advance Corporation. de | 11.8x | 18.4% | Mex$33.2b |
GCC * GCC. de | 8.7x | -1.6% | Mex$56.9b |
CMOCTEZ * Corporación Moctezuma. de | 9.6x | 2.5% | Mex$64.1b |
CYDSASA A Cydsa. de | 8x | 20.9% | Mex$9.0b |
NGVT * Ingevity | 9.7x | 15.3% | Mex$2.0b |
Price-To-Earnings vs Peers: NGVT * is expensive based on its Price-To-Earnings Ratio (9.7x) compared to the peer average (8.3x).
Price to Earnings Ratio vs Industry
How does NGVT *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
37 Companies | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
37 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Earnings vs Industry: NGVT * is good value based on its Price-To-Earnings Ratio (9.7x) compared to the Global Chemicals industry average (21.2x).
Price to Earnings Ratio vs Fair Ratio
What is NGVT *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 9.7x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NGVT *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
CRH
UK£32.3b
Provides building materials solutions in Ireland and internationally.
CRH N
UK£960.44
7D
0%
1Y
48.5%
Celanese
US$8.2b
A chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally.
CE *
US$1,495.25
7D
n/a
1Y
n/a
FMC
US$7.3b
An agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products.
FMC1 *
US$1,246.00
7D
0%
1Y
n/a